Empfehlung
47,1
Halten
Composite Score (0–100)
Insider (25%)
89.3
6 Insider, 138,5M $ Volumen
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
88.3
13D-Filing vorhanden
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Stammdaten
Unternehmen
| Name | Aktis Oncology, Inc. |
|---|---|
| Ticker | AKTS |
| CIK | 0002035832 |
Branche
| SIC-Code | 2834 |
|---|---|
| Beschreibung | Pharmaceutical Preparations |
Wertpapier
| CUSIP | 01021M104 |
|---|---|
| ISIN | US01021M1045 |
| Typ | Common Stock |
| Titel | Aktis Oncology, Inc. |
Status
| Zuletzt geprüft | 2026-03-20 22:36:35.149894 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-01-12 | Foley Todd | Director, 10% Owner | Open Market Purchase | 232,870 | 18.00 | 4,191,660.00 | +33,3% | |
| 2026-01-12 | Foley Todd | Director, 10% Owner | Open Market Purchase | 232,870 | 18.00 | 4,191,660.00 | +33,3% | |
| 2026-01-12 | Kim Helen Susan | Director, 10% Owner | Open Market Purchase | 812,455 | 18.00 | 14,624,190.00 | +116,1% | |
| 2026-01-12 | Kim Helen Susan | Director, 10% Owner | Open Market Purchase | 22,545 | 18.00 | 405,810.00 | +3,2% | |
| 2026-01-12 | EcoR1 Capital, LLC | Director | Open Market Purchase | 2,077,779 | 18.00 | 37,400,022.00 | +297,0% | |
| 2026-01-12 | EcoR1 Capital, LLC | Director | Open Market Purchase | 144,443 | 18.00 | 2,599,974.00 | +20,6% | |
| 2026-01-12 | MPM BIOVENTURES 2018, L.P. | 10% Owner | Open Market Purchase | 1,112,777 | 18.00 | 20,029,986.00 | +159,0% | |
| 2026-01-12 | Vida Ventures II, LLC | 10% Owner | Open Market Purchase | 812,455 | 18.00 | 14,624,190.00 | +116,1% | |
| 2026-01-12 | Vida Ventures II, LLC | 10% Owner | Open Market Purchase | 22,545 | 18.00 | 405,810.00 | +3,2% | |
| 2026-01-12 | GADICKE ANSBERT | 10% Owner | Open Market Purchase | 1,112,777 | 18.00 | 20,029,986.00 | +159,0% | |
| 2026-01-12 | GADICKE ANSBERT | 10% Owner | Open Market Purchase | 1,112,777 | 18.00 | 20,029,986.00 | +159,0% |
Fail-to-Deliver (6 Monate)
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-02-27 | 602 | 19,63 | 11.817 |
| 2026-02-25 | 2.851 | 20,00 | 57.020 |
| 2026-02-24 | 5.761 | 19,43 | 111.936 |
| 2026-02-17 | 14.136 | 17,76 | 251.055 |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.